Fidelity Investments’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-52
| Closed | -$1.1K | – | 5588 |
|
2023
Q2 | $1.1K | Sell |
52
-270
| -84% | -$5.7K | ﹤0.01% | 4694 |
|
2023
Q1 | $8.68K | Sell |
322
-537
| -63% | -$14.5K | ﹤0.01% | 4185 |
|
2022
Q4 | $30.4K | Buy |
859
+43
| +5% | +$1.52K | ﹤0.01% | 3626 |
|
2022
Q3 | $184K | Buy |
816
+1
| +0.1% | +$225 | ﹤0.01% | 3071 |
|
2022
Q2 | $154K | Buy |
815
+802
| +6,169% | +$152K | ﹤0.01% | 3201 |
|
2022
Q1 | $3K | Buy |
+13
| New | +$3K | ﹤0.01% | 4608 |
|
2021
Q3 | – | Sell |
-6
| Closed | -$1K | – | 5188 |
|
2021
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 4134 |
|
2015
Q2 | – | Sell |
-736
| Closed | -$6.28M | – | 2825 |
|
2015
Q1 | $6.28M | Buy |
+736
| New | +$6.28M | ﹤0.01% | 2155 |
|